20 June 2025 BCMA-targeted CAR T cell therapies like idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel) have dramatically changed the treatment landscape for relapsed/refractory multiple
20 June 2025 Immune Thrombocytopenia (ITP) is an autoimmune condition where the body’s immune system mistakenly attacks its own platelets, the tiny cells essential for